Introduction
Few diseases are as strongly affi liated with fear as cancer. Th e emotional reactions range from moderate worry to disorders that meet the full DSM-IV criteria [1] . Th ey are commonly caused by the severity of physical complaints and not related to neurotic confl icts. Although psychosocial care is becoming more widely available due to higher numbers of specialized cancer centres, the extent of distress is often not identifi ed and therefore not adequately treated [2] . Th is can lead to increased mortality [3] , reduced quality of life [4] , worsening of compliance [5] and prolonged hospitalization [6] . Underestimation of emotional side eff ects is caused by defi cient training in recognizing distress [7] and an inability to communicate emotional issues [8] , a lack of time for suffi cient contact as well as economical and institutional circumstances [9] .
Patients expect the physician to address such topics actively since the majority fears additional stigmatization through a psychiatric diagnosis when they communicate such problems themselves. Complicating the matter further, the interest of cancer patients in psychological support correlates more with gender, age and individual coping strategies rather than a high burden of distress or the presence of a psychiatric diagnosis [10] .
Th erefore comprehensive care for cancer patients requires knowledge about psychiatric disorders as well as detailed diagnostic and therapeutic skills to provide a competent treatment of both somatic and psychological needs.
Epidemiology
To develop cancer exceeds coping resources in 30-40% of the aff ected persons [1] , leading to one (20%) or more (11.6%) mental disorders [11] . Th e most frequent diagnoses involve aff ective disorders: major or minor depression or dysthymia. A recently published meta-analysis (94 interview-based studies with 14,078 individuals in hospital settings) revealed a lesser prevalence when diagnosis was achieved in interviews as opposed to other methods such as screening questionnaires [1] . Point prevalence of aff ective disorders in general population is 6% in men and 10% in women. Th e percentages in cancer patients are much higher with 20.7% and 24.6% in palliative care settings, respectively [1] . Other authors describe even 3-5 times higher incidence than in the general population [12] . Interestingly, anxiety disorders by DSM or ICD criteria (like generalized anxiety disorder, panic disorder, agoraphobia, specifi c or social phobia) do not occur more frequently in cancer patients (2-16%) [11] than in the general population (5% in men, 12 % woman) [13] during acute care. Adjustment disorders are found notably more frequently in cancer patients (15-19%) [1] , point prevalence of posttraumatic disorder occurs in 3-6% [14] . A current meta-analysis [1] found no eff ect of age, sex or clinical setting.
Risk factors
Th e development of psychiatric co-morbidity in cancer patients is best described as a continuum beginning with small Anxiety and depression disorders in cancer patients: incidence, diagnosis and therapy memo Anxiety and depression disorders in cancer patients 1/2012 short review 53 © Springer-Verlag distress, followed by adjustment disorder and fi nally leading to depressive or anxiety disorder. Risk factors are categorized into biological, psychological and social components. For example, the individual aetiology of the often noticeable fatigue syndrome, which appears similar to depressive mood, is possibly caused by neurobiological or hormonal changes as well as by tumour or therapy induced infl uences [16] . Important to consider are the depressive symptoms as unwanted side eff ects after medical treatment, e.g. with cytokine IL-2 or interferonalpha (IFN-α), observed in one-third of patients under therapy [17] . Psychological factors include among others coping strategies or previous history of mental disorders. Social factors like familiar or social support play an important role, too.
Prognostic relevant risk factors for depression are biological factors like younger age, previous history of depression and advanced disease as well as psychological factors like subjective perceived social support, less optimism, less self confi dence and social factors like a lack of social support, recent losses and previous history of trauma [18] .
Risk factors for adjustment disorders are advanced and severe disease, worse prognosis, early onset, low functional status, pain, living alone and worry about being strain for others [15] as well as having underage children [19] .
Diagnostic of mental disorders
It has been shown that most patients do not express their emotional concerns and needs for psychosocial support [10] . Reasons for that are often fear of additional stigmatization or denial. To disregard anxiety is not as feasible as disregarding depression, which could be interpreted as adjustment to disorder. Interaction eff ects between disease-or therapy-induced symptoms and mood variations possibly complicate assessment of mental disorders, often observed during shock of primary diagnosis, ongoing chemotherapy or under vigorous pain [19] . Th is leads to under-or overestimation of prevalence resulting in a signifi cant lack of support [20] .
Cancer-specifi c screening instruments were developed to detect patients with signifi cant needs. Th ey shall be used ahead of or at least parallel to existing somatic diagnostic routine and shall be applied to each patient systematically according to international guidelines [21] .
Established instruments are the Hospital Anxiety and Depression Scale, HADS [22] and the NCCN-distress thermometer. Th e most common valid, but time-consuming instrument is the "Structured Clinical Interview for DSM-Disorders, SCID" [23] .
Acute stress disorder
Th e symptoms of crisis (psychological shock, emotional numbing, restriction of consciousness, inability to handle stimuli, vegetative arousal) start within minutes and ease within hours or days. Most patients cope with this situation by themselves. Assistance from personnel who are also competent with respect to medical issues is very helpful in that situation.
Adjustment disorders
Adjustment disorders with both depressive or anxiety symptoms arise when adaptation was not successful and should only be diagnosed when no other major mental disorder or bereavement exists. Th e perception of not coming back to routine after the distressing event and signifi cant impairment in functioning is central. Symptoms of irritability, aggressiveness and sleep disorders can strongly aff ect the cancer patients. Th e disorder lasts generally for several months and shall be treated by psychotherapeutic interventions.
Posttraumatic stress disorder (PTSD)
PTSD is a reaction to a traumatic event of a life-threatening illness such as cancer. Th ose patients often present very frightened, helpless or horrifi ed state. Th is category may only be assigned within six months from the appearance of the event and in absence of anxiety or depressive disorders. Th ree leading symptoms are characteristic: intrusion, avoidance and arousal. Eff ective therapeutic approaches are, for example, EMDR (Eye Movement Desensitization and Reprocessing) and imaginative techniques to stabilize the patients.
Anxiety
Anxiety has cognitive appraisal, aff ective, behavioural and physiological components, which are sometimes diffi cult to distinguish from specifi c side eff ects of therapy, e.g. nausea.
In the context of cancer, anxiety is adaptive and activates resources to avoid danger.
Maladaptive anxiety leads to inappropriate thoughts, activities or impairments. Debilitating fear of recurrence, exacerbation of previous anxiety disorder or therapy-induced traumata in acute care like lack of oxygen in lung cancer can lead to maladaptive anxiety. Anxiety can be alleviated through psycho-educative interventions, e.g. "normalizing" of symptoms or clarifi cation of the immediate contents. In acute hospital care it is common to use anxiolytics, which should not be used in outpatient, non-palliative settings because of their highly addictive potential.
Depression
Sadness after confrontation with cancer disease or recurrence is adequate. However, clinically signifi cant depression with leading symptoms of depressed mood, loss of interest and anhedonia is often not suffi ciently recognized and treated. Depression causes decreased quality of life and aff ects compliance which possibly leads to adverse process of disease [25] and prolonged hospitalization [6] . Diagnostic distinguishes between depressive reaction within adjustment disorders, major or minor depressive episode, dysthymia and cancer-specifi c impairments of mood. Half of aff ected patients remain undetected [26] although appropriate treatment is needed and eff ective. Patients with a reliable diagnosis of major depression should be treated with combined therapy consisting of psychotherapy and psychopharmacotherapy. Important for choice of medication is age, general status, risk of interaction and profi le of side eff ects. New antidepressants with more favourable profi le of side eff ects, notably less risk of cytochrom p450-interaction, are used [27] . In case of agitate behaviours anxiolytics may be necessary; in case of delusion neuroleptics shall be used. However, at present the use of pharmacotherapy is not well examined in cancer care and there are no existing guidelines for diff erentiated prescrip-
Differentiated diagnosis
Before a mental diagnosis can be established, it is important to exclude somatic aspects like thyroid dysfunction, cerebral or neurological alterations. In addition it is necessary to consider sequelae of cancer disease (e.g. cachexia, anaemia) together with their impacts fatigue, decrease of concentration and reduced functionality. Recently two studies impressively could show the positive infl uence of early palliative care intervention on cancer patients' mood [30, 31] . Th erefore an early involvement of palliative care specialists would be reasonable.
Therapy
Th e goal of psycho-oncology is to reduce distress, anxiety and depression and to strengthen communication with the social environment, to rediscover resources and thereby enhance quality of life of cancer patients. Interventions are individually tailored to kind and severity of symptoms. In addition to psychotherapeutic interventions pharmaceutical therapies shall be used in major disorders. Results of diff erent meta-analyses lead to evidence-grade-I for psycho-oncological interventions [32] . Cognitive-behavioural and supportive-expressive treatments as well as relaxation trainings and most notably psycho-educational group programs have been found eff ective. Nevertheless, getting appropriate help often turns out to be challenging for cancer patients in routine care.
Take-home message
Each cancer patient needs appropriate information about his or her disease, including options for somatic and psychological therapy. A screening for mental disorders followed by initiation of adequate therapy results in improved quality of life.
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